the results are not negative, in fact they are positive. - but there is an inconsistency.
in one discreet half of the trial - the drug provided significant benefit over the vehicle
in the other discreet half of the trial - both the vehicle and the drug provided equal and significant benefit
if both the vehicle and the drug provided no benefit equally, that is a failure. and is not the case.
how can our vehicle ("placebo") outperform the next best commercial product?
is a simple mistake plausible in this scenario?
yes.
the results are not negative, in fact they are positive. - but...
-
- There are more pages in this discussion • 506 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.020(6.15%) |
Mkt cap ! $624.4M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 34.5¢ | 32.5¢ | $2.676M | 7.955M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 19000 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 48210 | 1 |
View Market Depth
| Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |